Clinical Trial Update: Cerliponase Alfa Observational Study in the US

View source ↗

Summary

An update on an observational US study of cerliponase alfa for late-infantile neuronal ceroid lipofuscinosis type 2, noting the study is active but not recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Late-infantile Neuronal Ceroid Lipofuscinosis Type

Drugs mentioned

• BRINEURA (cerliponase alfa)

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 | Status: ACTIVE_NOT_RECRUITING